FDA Unveils New Guidance, Plans to Boost Access to Generics

Drug Industry Daily
A A
FDA Commissioner Scott Gottlieb on Friday announced the release of draft guidance on a new approval pathway for generic drugs and said the agency will roll out new policies over the next year aimed at increasing access to generics and boosting price competition for branded drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily